Lincoln Pharmaceuticals sets Sept. 30, 2026 as AGM record date; book closure runs Sept. 12–30
Lincoln Pharmaceuticals set Sept. 30, 2026 as the record date for its 32nd annual general meeting, with the share transfer books to remain closed from Sept. 12 to Sept. 30. The company proposed a final dividend of 1.80 rupees per share of face value 10 rupees, equivalent to an 18% payout. For the quarter ended June 30, 2026, it reported consolidated net profit rising 30.90% year-on-year to 36.23 crore rupees, while total income increased 19.02% to 201.55 crore rupees. EBITDA for the quarter grew 32.29% to 51.70 crore rupees.